Brent K. Blackburn is SVP & Drug Discovery & Dev at CV THERAPEUTICS INC (CVTX). They have made 1 open-market trade across 1 company since 2007, most recently 2009-04-02.
CIK 0001238402
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CVTX | 56,370 | — |
Shares reported on the most recent Form 4, priced at the 2009-04-03 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CVTX | SELL · 10b5-1 | 2009-01-07 | 2009-01-07 | $9.38 | $14K | N/A | N/A | N/A |
| CVTX | SELL · 10b5-1 | 2008-11-06 | 2008-11-06 | $10.49 | $21K | N/A | N/A | N/A |
| CVTX | SELL · 10b5-1 | 2008-10-14 | 2008-10-15 | $8.93 | $18K | N/A | N/A | N/A |
| CVTX | SELL · 10b5-1 | 2008-09-09 | 2008-09-09 | $11.50 | $15K | N/A | N/A | N/A |
| CVTX | SELL · 10b5-1 | 2008-08-13 | 2008-08-13 | $10.17 | $15K | N/A | N/A | N/A |
| CVTX | SELL · 10b5-1 | 2008-07-31 | 2008-08-01 | $9.50 | $119K | N/A | N/A | N/A |
| CVTX | SELL · 10b5-1 | 2008-07-08 | 2008-07-09 | $7.61 | $10K | N/A | N/A | N/A |
| CVTX | SELL · 10b5-1 | 2008-06-17 | 2008-06-18 | $7.93 | $7K | N/A | N/A | N/A |
| CVTX | SELL · 10b5-1 | 2008-04-25 | 2008-04-29 | $9.51 | $119K | N/A | N/A | N/A |
| CVTX | SELL · 10b5-1 | 2008-01-10 | 2008-01-10 | $9.50 | $95K | N/A | N/A | N/A |
| CVTX | SELL · 10b5-1 | 2007-12-11 | 2007-12-12 | $9.72 | $184K | N/A | N/A | N/A |
| CVTX | SELL | 2007-08-16 | 2007-08-17 | $10.09 | $101K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.